Tcm Group As · OMXCOP:TCM

Tcm Group As — Q1 2025 Earnings Presentation

9 slides from Tcm Group As's earnings presentation, May 21, 2025

  1. Slide 1: TCM Group A/S Interim Report January - March 2025

    TCM Group A/S Interim Report January - March 2025 May 21, 2025

  2. Slide 2: Business update Q1 2025

    Business update Q1 2025  Year on year revenue growth of 5.3%, with an organic growth of 3.6%.  Revenue in Q1 of DKK 308 million vs. DKK 293 million last year.  Robust increase in B2C sales.  Positive sales development in Norway, +11.2%  Total order-intake up on Q1 2024 due to growth in both B2C

  3. Slide 3: Q1: Revenue growth, improved earnings

    Q1: Revenue growth, improved earnings 1 Revenue: 308 mDKK (293 mDKK) 2 Organic growth: 4% YoY 3 Adjusted EBIT: 17 mDKK (16 mDKK) 4 Adjusted EBIT-margin: 5.6 % (5.4%) 5 NWC ratio: -0.3% (-0.8%) 6 Cash conversion: 76.8% (69.1%) 3

  4. Slide 4: Revenue development

    Revenue development Revenue development Q1 comments:  Organic revenue increase of 3.6%.  Organic revenue growth in Denmark of 2.0%.  Revenue in Norway increased by 11.2% after a period of very difficult trading.  Decreased share of lower-margin third-party sales 4

  5. Slide 5: Income statement highlights

    Income statement highlights Gross margin EBIT and EBIT margin Q1 comments:  Gross margin improved to 21.1% (20.5%).  Uplift driven by the acquisition of two Svane Køkkenet stores in Denmark.  Benefit from improved sales mix diluted by higher production and logistics costs.  Higher OPEX due to th

  6. Slide 6: Net working capital and NIBD

    Net working capital and NIBD Net working capital Net interest-bearing debt Comments:  NWC ratio -0.3% (-0.8%)  NIBD reduced from DKK 347m to DKK 332m.  Leverage ratio of 2.6 (3.7 Q1 LY). 6

  7. Slide 7: Cash flow

    Cash flow Free cash-flow Q4 comments:  Free cash flow was DKK -4m compared to DKK 13m in Q1 LY.  Capex ratio was 2.2% of revenue compared to 1.0% in Q1 LY.  Cash conversion (LTM) of 77%. 7

  8. Slide 8: Financial outlook 2025

    Financial outlook 2025 Financial outlook maintained:  Net revenue: DKK 1,250-1,400 million  Adjusted EBIT: DKK 90-120 million  Acquisition of Celebert ApS expected in the 2nd half of the year. (EBIT excluding non-recurring items) Revenue development Adjusted EBIT development DKKm DKKm 1,250 - 1,4

  9. Slide 9: Q&A

    Q&A

TCM Group — Q1 2025 Earnings Presentation on 6ix